000 | 01826 a2200529 4500 | ||
---|---|---|---|
005 | 20250513073734.0 | ||
264 | 0 | _c19930923 | |
008 | 199309s 0 0 eng d | ||
022 | _a0264-410X | ||
024 | 7 |
_a10.1016/0264-410x(93)90361-z _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMiyazaki, C | |
245 | 0 | 0 |
_aImmunization of institutionalized asthmatic children and patients with psychomotor retardation using live attenuated cold-adapted reassortment influenza A H1N1, H3N2 and B vaccines. _h[electronic resource] |
260 |
_bVaccine _c1993 |
||
300 |
_a853-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAsthma _xblood |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Institutionalized |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aCold Temperature |
650 | 0 | 4 |
_aCross Infection _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunization |
650 | 0 | 4 | _aInfluenza A Virus, H1N1 Subtype |
650 | 0 | 4 | _aInfluenza A Virus, H3N2 Subtype |
650 | 0 | 4 |
_aInfluenza A virus _ximmunology |
650 | 0 | 4 |
_aInfluenza B virus _ximmunology |
650 | 0 | 4 |
_aInfluenza Vaccines _xadverse effects |
650 | 0 | 4 |
_aInfluenza, Human _xblood |
650 | 0 | 4 |
_aPsychomotor Disorders _xblood |
650 | 0 | 4 |
_aReassortant Viruses _ximmunology |
650 | 0 | 4 |
_aVaccines, Attenuated _xadverse effects |
700 | 1 | _aNakayama, M | |
700 | 1 | _aTanaka, Y | |
700 | 1 | _aKusuhara, K | |
700 | 1 | _aOkada, K | |
700 | 1 | _aTokugawa, K | |
700 | 1 | _aUeda, K | |
700 | 1 | _aShibata, R | |
700 | 1 | _aNishima, S | |
700 | 1 | _aYamane, N | |
773 | 0 |
_tVaccine _gvol. 11 _gno. 8 _gp. 853-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0264-410x(93)90361-z _zAvailable from publisher's website |
999 |
_c8356122 _d8356122 |